The Use of Real World Evidence to Accelerate MedTech HTA Approval
Our panellists are: Michael Branagan-Harris - CEO, Device Access UK Mattias Kyhlstedt - CEO, Synergus Professor Tom Clutton-Brock FRCP, FRCA, FFICM- Director, Medical Devices Testing and Evaluation Centre & Chair, NICE Interventional Procedures Advisory Committee Dr Peter Walton - Managing Director, Dendrite Clinical Systems